Search Results - "van Dalen, F. J."

Effect of Antigen Valency on Autoreactive B‑Cell Targeting by van Weijsten, M. J., Venrooij, K. R., Lelieveldt, L.P.W.M., Kissel, T., van Buijtenen, E., van Dalen, F. J., Verdoes, M., Toes, R.E.M., Bonger, K. M.

“…Many autoimmune diseases are characterized by B cells that mistakenly recognize autoantigens and produce antibodies toward self-proteins. Current therapies aim…”
Get full text

Cost benefit analysis of early thrombolytic treatment with intracoronary streptokinase. Twelve month follow up report of the randomised multicentre trial conducted by the Interuniversity Cardiology Institute of The Netherlands by Vermeer, F, Simoons, M L, de Zwaan, C, van Es, G A, Verheugt, F W, van der Laarse, A, van Hoogenhuyze, D C, Azar, A J, van Dalen, F J, Lubsen, J

“…The costs and benefits of early thrombolytic treatment with intracoronary streptokinase in acute myocardial infarction were compared in a randomised trial. All…”
Get full text

Comparison of costs of percutaneous transluminal coronary angioplasty and coronary bypass surgery for patients with angina pectoris by van den Brand, M, van Halem, C, van den Brink, F, de Feyter, P, Serruys, P, Suryapranata, H, Meeter, K, Bos, E, van Dalen, F J

“…To determine the costs of a procedure, the total costs of the department that provides the service must be considered and, in addition, the direct cost of the…”
Get more information

Usefulness of pimobendan in the treatment of heart failure by Duncker, D J, van Dalen, F J, Hartog, J M, Lamers, J M, Rensen, R J, Saxena, P R, Verdouw, P D

“…The effects of the benzimidazole-pyridazinone pimobendan (UD-CG 115 BS) on systemic haemodynamics, myocardial performance and the distribution of cardiac…”
Get more information

Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial by Poole-Wilson, Philip A, Lubsen, Jacobus, Kirwan, Bridget-Anne, van Dalen, Fred J, Wagener, Gilbert, Danchin, Nicolas, Just, Hanjörg, Fox, Keith AA, Pocock, Stuart J, Clayton, Tim C, Motro, Michael, Parker, John D, Bourassa, Martial G, Dart, Anthony M, Hildebrandt, Per, Hjalmarson, Åke, Kragten, Johannes A, Molhoek, G Peter, Otterstad, Jan-Erik, Seabra-Gomes, Ricardo, Soler-Soler, Jordi, Weber, Simon

“…Calcium antagonists are widely prescribed for angina pectoris but their effect on clinical outcome is controversial. We aimed to investigate the effect of the…”
Get full text

Safety of nifedipine GITS in Stable Angina : The ACTION trial by POOLE-WILSON, Philip A, KIRWAN, Bridget-Anne, VOKO, Zoltan, DE BROUWER, Sophie, VAN DALEN, Fred J, LUBSEN, Jacobus

“…We describe the safety profile of nifedipine GITS as assessed from adverse events reported in the ACTION trial in which 7,665 patients with stable, symptomatic…”
Get full text

Design and current status of ACTION: A Coronary disease Trial Investigating Outcome with Nifedipine GITS. Gastro-Intestinal Therapeutic System by Lubsen, J, Poole-Wilson, P A, Pocock, S J, van Dalen, F J, Baumann, J, Kirwan, B A, Parker, A B

“…To present the design of ACTION (A Coronary disease Trial Investigating Outcome with Nifedipine GITS), an ongoing multicentre clinical outcome trial with…”
Get full text

Quality management of a large randomized double-blind multi-centre trial: The ACTION experience by Kirwan, Bridget-Anne, Lubsen, Jacobus, Brouwer, Sophie de, van Dalen, Frederik J, Pocock, Stuart J, Clayton, Tim, Danchin, Nicolas, Poole-Wilson, Philip A

“…Abstract The ACTION (A Coronary disease Trial Investigating Outcome with Nifedipine GITS) study was an independent, investigator-initiated, multi-national…”
Get full text

Design and current status of ACTION : A coronary disease Trial Investigating Outcome with Nifedipine GITS: Sustained release calcium channel antagonists: the ultimate solution? by LUBSEN, J, POOLE-WILSON, P. A, POCOCK, S. J, VAN DALEN, F. J, BAUMANN, J, KIRWAN, B. A, PARKER, A. B

Get full text